FDA PMA FDA Class 3 Approved 🇺🇸 United States

Cardiac Ablation Percutaneous Catheter

PMA: P020045 · Supplement: S092 · Decision Mar 2, 2020
Classifications
1
FEI Numbers
52
Registration Numbers
52

Basic Information

Device Name
Cardiac Ablation Percutaneous Catheter
Trade Name
Freezor Cardiac Cryoablation Catheter
PMA Number
P020045
Supplement Number
S092
Device Class
FDA Class 3
Product Code
LPB
Generic Name
Cardiac ablation percutaneous catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
March 2, 2020
Date Received
December 19, 2019
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for an alternate manufacturing site (Medtronic Mexico, Tijuana Baja California, Mexico), as well as a new sterilization site (Midwestern Sterilization, Jackson, Missouri)and packaging improvements for Coaxial umbilical component of the CryoAblation System.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LPB Cardiac Ablation Percutaneous Catheter